NEW YORK, Nov. 14, 2018 /PRNewswire/ — Abyrx, Inc. (http://abyrx.com), a leading biomaterial sciences company with an initial focus on therapeutic technologies for use during surgical procedures, announced today that Gary D. Cohn has joined the company’s board of directors.

Click here to read the article.